6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+12.56%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$1.08B
AUM Growth
+$1.08B
(+8.4%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
53.81%
Holding
156
New
15
Increased
21
Reduced
14
Closed
14
Top Buys
| 1 |
FirstEnergy
FE
|
$64.2M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$50M |
| 3 |
Wells Fargo
WFC
|
$19.3M |
| 4 |
Enova International
ENVA
|
$15.9M |
| 5 |
Cardlytics
CDLX
|
$10.2M |
Top Sells
| 1 |
Carvana
CVNA
|
$139M |
| 2 |
Ventas
VTR
|
$9.16M |
| 3 |
HOME
At Home Group Inc.
HOME
|
$8.17M |
| 4 |
ARYBU
ARYA Sciences Acquisition Corp II Unit
ARYBU
|
$8.12M |
| 5 |
IAC Inc
IAC
|
$5.99M |
Sector Composition
| 1 | Consumer Discretionary | 21.97% |
| 2 | Healthcare | 21.19% |
| 3 | Communication Services | 14.09% |
| 4 | Financials | 11.13% |
| 5 | Utilities | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Carvana
CVNA
$51.4B
| $167M | 12.25% | 750,000 -623,423 | -45% | -$139M |
|
|
2
Cardlytics
CDLX
$54.3M
| $70.6M | 5.17% | 1,000,774 +144,168 | +17% | +$10.2M |
|
|
3
FirstEnergy
FE
$25.2B
| $64.2M | 4.7% | +2,236,409 | New | +$64.2M |
|
|
4
IAC Inc
IAC
$2.94B
| $55.5M | 4.06% | 463,000 -50,050 | -10% | -$5.99M |
|
|
MMP
5
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $50M | 3.66% | +1,460,732 | New | +$50M |
|
6
Amazon
AMZN
$2.44T
| $37.8M | 2.77% | 12,000 | – | – |
|
7
Capital One
COF
$145B
| $35.3M | 2.59% | 491,617 | – | – |
|
|
8
Enova International
ENVA
$3.03B
| $34.7M | 2.54% | 2,119,423 +971,365 | +85% | +$15.9M |
|
9
PG&E
PCG
$33.6B
| $33.7M | 2.46% | 3,583,929 +400,713 | +13% | +$3.76M |
|
10
Diageo
DEO
$62.1B
| $30M | 2.2% | 218,000 +28,000 | +15% | +$3.85M |
|
|
11
Wells Fargo
WFC
$263B
| $23.5M | 1.72% | 1,000,000 +820,000 | +456% | +$19.3M |
|
|
EIGR
12
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $21.4M | 1.56% | 2,622,914 +466,075 | +22% | +$3.79M |
|
13
Adient
ADNT
$2.01B
| $20.9M | 1.53% | 1,203,588 | – | – |
|
14
uniQure
QURE
$896M
| $17.7M | 1.29% | 480,000 | – | – |
|
15
Altria Group
MO
$113B
| $17.5M | 1.28% | 453,860 | – | – |
|
|
B
16
Barrick Mining Corporation
B
$45.4B
| $15.8M | 1.16% | 561,477 | – | – |
|
17
Alnylam Pharmaceuticals
ALNY
$58.5B
| $15.3M | 1.12% | 105,000 | – | – |
|
18
Angi Inc
ANGI
$786M
| $12.8M | 0.93% | 1,149,673 +100,000 | +10% | +$1.11M |
|
|
MRNS
19
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $12.5M | 0.91% | 971,718 +46,336 | +5% | +$595K |
|
|
AFMD
20
DELISTED
Affimed
AFMD
| $12.4M | 0.91% | 3,650,000 | – | – |
|
21
Syndax Pharmaceuticals
SNDX
$1.41B
| $12.2M | 0.9% | 828,371 -188,000 | -18% | -$2.77M |
|
22
Ardelyx
ARDX
$1.53B
| $11.9M | 0.87% | 2,268,798 +114,614 | +5% | +$602K |
|
23
Immatics
IMTX
$619M
| $11.1M | 0.82% | 1,050,000 | – | – |
|
|
DRTT
24
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
| $11M | 0.81% | 7,069,735 +551,735 | +8% | +$862K |
|
|
PRVB
25
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $11M | 0.81% | 859,314 +259,314 | +43% | +$3.33M |
|